Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
181 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
182 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Asmaa Mohamed Zahran Omar 2021
183 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
184 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2021
185 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
186 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Pathology Saly Salah Abdelhakeem 2021
187 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Pediatric Oncology ِAyat Abd El Aleem 2021
188 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Alia Mohamed Ali Attia 2021
189 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
190 First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021